Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.650.600.620.600.64

What is the latest Fixed Capital/Sales ratio of EMCURE PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of EMCURE PHARMACEUTICALS is 0.65 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.65
Mar20230.60
Mar20220.62
Mar20210.60
Mar20200.64

How is Fixed Capital/Sales of EMCURE PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.65
8.33
Mar2023 0.6
-3.23
Mar2022 0.62
3.33
Mar2021 0.6
-6.25
Mar2020 0.64 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹19,156.6 Cr -8.1% 0.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-8.1%

0.4%

NA
SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses